LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

A patient with end-stage kidney disease successfully received a genetically engineered porcine kidney and was released from ...

While Donald Trump spared pharma companies from his tariff announcement last week, he revealed yesterday plans to announce ...

With biotech firms caught in the crosshairs of Trump’s tariffs, the levy could prove to be a boon for domestic producers but ...

Biotechnology will have a transformative impact on defense, supply chains, agriculture, health and computing, all areas that ...

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

Dutch rare diseases biotech firm ProQR Therapeutics (Nasdaq: PRQR) today announced the appointment of Dr Cristina Lopez Lopez ...

A week after President Trump instituted broad tariffs on imports during his “Liberation Day,” he abruptly announced yesterday ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

Expiring patents can be a catalyst for M&A in the life sciences industry as pharmaceutical and biotechnology companies seek ...

Is the biotech job market improving in 2025? Explore the latest trends and opportunities in the industry after a challenging few years.